Skip NavigationSkip to Content

Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii

  1. Author:
    Diyabalanage, T.
    Ratnayake, R.
    Wilson, J. A.
    Henrich, C. J.
    Beutler, J. A.
    Colburn, N. H.
    McMahon, J. B.
    Gustafson, K. R.
  2. Author Address

    [Diyabalanage, T; Ratnayake, R; Wilson, JA; Henrich, CJ; Beutler, JA; McMahon, JB; Gustafson, KR] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA [Henrich, CJ] NCI, SAIC Frederick, Frederick, MD 21702 USA [Colburn, NH] NCI, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21702 USA;Gustafson, KR (reprint author), NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA;gustafki@mail.nih.gov
    1. Year: 2011
    2. Date: Aug
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 21
    2. 15
    3. Pages: 4397-4399
  2. Type of Article: Article
  3. ISSN: 0960-894X
  1. Abstract:

    A high throughput screen for inhibitors of the oncogenic transcription factor activator protein-1 (AP-1) was applied to the NCI repository of natural product extracts. The liphophilic extract of the plant Nothospondias staudtii (Simaroubaceae) displayed significant AP-1 inhibition. Bioassay-guided fractionation of the extract lead to a new quassinoid named nothospondin (1), and the known compound glaucarubinone (2). The structure of 1 was elucidated by spectroscopic methods. Compounds 1 and 2 showed potent, dose-dependent AP-1 inhibition at noncytotoxic concentrations. Published by Elsevier Ltd.

    See More

External Sources

  1. DOI: 10.1016/j.bmcl.2011.06.044
  2. WOS: 000292729900004

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel